SAB CAPRA, LLC

North Salt Lake, UT · Biotech · Private

Transchromosomic goats (TcGs) engineered to produce fully human therapeutic and diagnostic antibodies using human artificial chromosomes (HAC) and CRISPR/Cas9 gene editing

sabcapra.com →
Grants
$2.5M
3 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Production and Characterization of Human Immunoglobulin Producing Goats for Diagnostic Reagents and Therapeutics$225,000
Federal grantDepartment of Health and Human Services · Phase II · Production and Characterization of Human Immunoglobulin Producing Goats for Diagnostic Reagents and Therapeutics$1,501,157
Federal grantDepartment of Health and Human Services · Phase II · Production and Characterization of Human Immunoglobulin Producing Goats for Diagnostic Reagents and Therapeutics$743,067
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2055CATENA BIOSCIENCES, INC.——
2056Aspen Stem Cell Institute, LLC——
2057HASENTECH, INC.——
2058SAB CAPRA, LLC——
2059Angitia Biopharmaceuticals——
2060RADTRAN LLC——
2061BIOAXONE BIOSCIENCES, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.